Pharmaceutical Drying Equipment Market - Global Forecast to 2029
商品番号 : SMB-68178
| 出版社 | MarketsandMarkets |
| 出版年月 | 2024年10月 |
| ページ数 | 227 |
| 図表数 | 273 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The global Pharmaceutical Drying Equipment market is projected to reach USD 8.18 billion by 2029 from USD 5.80 billion in 2024, at a CAGR of 7.1% during the forecast period.
世界の医薬品乾燥装置市場は、予測期間中に7.1%のCAGRで、2024年の58億米ドルから2029年までに81億8000万米ドルに達すると予測されています。
This is due to growing prevalence of chronic diseases such as diabetes, cardiovascular diseases, cancer, is leading to increase in demand for the pharmaceutical drugs. To meet this increased demand for the medicines the pharmaceutical manufacturing facilities are expanding, consequently increasing the demand for the pharmaceutical equipment dryers. However, the increased demand for the refurbished dryers in pharmaceutical industry is major restraint to the market. Additionally, Higher maintenance of the pharmaceutical drying equipment is major challenge for the market growth. But, the increasing competition in pharmaceutical manufacturing industry due to loss of various drugs’ market exclusivity and high growth potential of emerging markets is expected to present profitable growth opportunities for pharmaceutical drying equipment market players over the forecast period of 2024-2029.
“The spray dryer segment of pharmaceutical drying market to hold largest position forecast period.”
Based on the type, the spray dryer segment is anticipated to hold largest share position during forecast period in pharmaceutical drying equipment market. This is due to its versatility, efficiency, and ability to enhance product quality. It offers improved bioavailability by producing dust-free, free-flowing, and easily re-dispersible powders, making it ideal for thermoplastic, hygroscopic, and heat-sensitive products. Spray dryers are essential for maintaining quality of active pharmaceutical ingredient. As spray dryers can handle a wide variety of product types, including granulated and agglomerated forms, without heat deterioration. Its popularity in the sector is also a result of its small size, which guarantees energy-efficient operations and makes it an affordable option for large-scale pharmaceutical production.
“The pilot-scale equipment segment is the fastest growing segment in pharmaceutical drying equipment market.”
Based on scale of operation, the pharmaceutical drying equipment market is segmented into industrial-scale equipment, pilot-scale equipment, and laboratory-scale equipment. The pilot-scale equipment segment is expected to grow at the highest CAGR due to its pivotal role in pharmaceutical research and development (R&D). With increasing development of new medications, pilot-scale equipment allows manufacturers to test formulations and processes on a smaller, more cost-effective scale before full-scale industrial production. This affordability makes it an ideal choice during R&D, minimizing financial risk while optimizing production methods. Additionally, the growing trend of outsourcing manufacturing to Contract Development and Manufacturing Organizations (CDMOs) has further driven the demand for pilot-scale equipment. CDMOs use these systems to streamline the transition from R&D to large-scale production, ensuring efficient and scalable solutions for pharmaceutical companies. As more companies rely on CDMOs to bring new drugs to market, the need for pilot-scale equipment continues to rise, contributing to its rapid growth.
“Europe accounted for the second largest share of the pharmaceutical drying equipment market by region.”
The global pharmaceutical drying equipment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is the second largest regional market for pharmaceutical drying equipment, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.
Europe holds the second-largest position in the pharmaceutical drying equipment market. This is due to the presence of key industry players such as GEA Group (Germany), I.M.A. Industria Macchine Automatiche (Italy), Syntegon Technology GmbH (Germany), and Mechatech Systems Ltd (UK). These major European players are making significant investments in R&D to create cutting-edge, innovative equipment. Furthermore, the European region’s strong pharmaceutical manufacturing base, established regulatory framework, and focus on technological advancements all contribute to its strong market position. In Europe, the need for pharmaceutical drying equipment is being driven by innovation and industry leadership.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3– 30%
- By Designation: C-level–50%, Director-level–30% and Others–20%
- By Region: North America–38%, Europe–26%, Asia Pacific–15%, Latin America- 11%, and Middle east and Africa-10%
Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the pharmaceutical drying equipment market market are GEA Group (Germany), ATS Corporation (US), Hosokawa Micron Group (Japan), Freund Corporation (Japan), I.M.A. Industria Macchine Automatiche S.p.A. (Italy), Syntegon Technology GmbH (Germany), BUCHI Labortechnik AG (Switzerland), OPTIMA packaging group GmbH (Germany), Mechatech Systems Ltd (Netherland), and BEW Engineering Limited (India).
Research Coverage
This report studies the pharmaceutical drying equipment market based on type, scale of operation,, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Analysis of Key divers (The expansion of pharmaceutical manufacturing facilities to drive market growth, The increased demand for biopharmaceuticals to drive market, The rapid growth of the contact manufacturing companies to drive market), restraints (The demand for refurbished drying equipment is restraining the market) , Challenge (Higher maintenance of the pharmaceutical drying equipment is major challenge for the market), opportunity (Increasing competition in pharmaceutical manufacturing industry due to loss of various drugs’ market exclusivity, High growth potential of emerging markets)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the pain management devices market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the pharmaceutical drying equipment market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the pain management devices market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Table of Contents
1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
1.3 STUDY SCOPE 24
1.3.1 SEGMENTS AND REGIONS COVERED 24
1.3.2 INCLUSIONS & EXCLUSIONS 25
1.3.3 YEARS CONSIDERED 25
1.3.4 CURRENCY CONSIDERED 26
1.4 STAKEHOLDERS 26
1.5 SUMMARY OF CHANGES 26
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
2.1.1 SECONDARY DATA 28
2.1.1.1 Key objectives of secondary research 29
2.1.1.2 Key secondary sources 29
2.1.1.3 Key data from secondary sources 30
2.1.2 PRIMARY DATA 30
2.1.2.1 Key primary sources 31
2.1.2.2 Key objectives of primary research 31
2.1.2.3 Key data from primary sources 32
2.1.2.4 Key industry insights 32
2.2 MARKET SIZE ESTIMATION 33
2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 33
2.2.2 TOP-DOWN APPROACH 34
2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 34
2.2.4 DEMAND-SIDE ANALYSIS (USING PHARMACEUTICAL DRYING EQUIPMENT ADOPTION) 34
2.3 DATA TRIANGULATION 37
2.4 MARKET RANKING ANALYSIS 38
2.5 STUDY ASSUMPTIONS 39
2.6 RISK ASSESSMENT 39
2.7 RESEARCH LIMITATIONS 39
3 EXECUTIVE SUMMARY 40
4 PREMIUM INSIGHTS 43
4.1 PHARMACEUTICAL DRYING EQUIPMENT MARKET OVERVIEW 43
4.2 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2023 44
4.3 GEOGRAPHIC SNAPSHOT OF PHARMACEUTICAL DRYING EQUIPMENT MARKET,
2024–2029 45
4.4 PHARMACEUTICAL DRYING EQUIPMENT MARKET: REGIONAL MIX, 2022–2029 46
4.5 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DEVELOPED VS. EMERGING MARKETS, 2024 VS. 2029 (USD MILLION) 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
5.2.1 DRIVERS 48
5.2.1.1 Expansion of pharmaceutical manufacturing facilities 48
5.2.1.2 High demand for biopharmaceuticals 48
5.2.1.3 Rapid growth of contract manufacturing and development companies 48
5.2.2 RESTRAINTS 49
5.2.2.1 Increased demand for refurbished drying equipment 49
5.2.3 OPPORTUNITIES 49
5.2.3.1 Increased market competition and high demand for generic and biosimilar drugs 49
5.2.3.2 High growth potential in emerging economies 50
5.2.4 CHALLENGES 50
5.2.4.1 Need for regular maintenance and high associated costs 50
5.3 INDUSTRY TRENDS 50
5.3.1 AUTOMATION AND DIGITALIZATION 50
5.3.2 ENVIRONMENTAL SUSTAINABILITY 50
5.4 TECHNOLOGY ANALYSIS 51
5.4.1 KEY TECHNOLOGIES 51
5.4.1.1 Automation and control systems 51
5.4.1.2 Heat transfer technology 51
5.4.1.3 Vacuum technology 51
5.4.2 COMPLEMENTARY TECHNOLOGIES 51
5.4.2.1 High-efficiency particulate air (HEPA) filtration technology 51
5.4.2.2 Temperature control systems 52
5.4.2.3 Desorption technology 52
5.4.3 ADJACENT TECHNOLOGIES 52
5.4.3.1 Moisture sensors and monitoring systems 52
5.4.3.2 Air distribution systems 52
5.4.3.3 Particle size analysis technology 52
5.5 PORTER’S FIVE FORCE ANALYSIS 53
5.5.1 INTENSITY OF COMPETITIVE RIVALRY 54
5.5.2 BARGAINING POWER OF SUPPLIERS 54
5.5.3 BARGAINING POWER OF BUYERS 54
5.5.4 THREAT OF SUBSTITUTES 54
5.5.5 THREAT OF NEW ENTRANTS 54
5.6 KEY STAKEHOLDERS AND BUYING CRITERIA 55
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS 55
5.6.2 KEY BUYING CRITERIA 56
5.7 REGULATORY LANDSCAPE 56
5.7.1 REGULATORY ANALYSIS 57
5.7.1.1 North America 57
5.7.1.1.1 US 57
5.7.1.1.2 Canada 57
5.7.1.2 Europe 57
5.7.1.3 Asia Pacific 57
5.7.1.4 Latin America 58
5.7.1.5 Middle East & Africa 58
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 58
5.8 PATENT ANALYSIS 61
5.8.1 PATENT PUBLICATION TRENDS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET 61
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 61
5.9 TRADE ANALYSIS 64
5.9.1 IMPORT DATA FOR HS CODE 8419 64
5.9.2 EXPORT DATA FOR HS CODE 8419 65
5.10 PRICING ANALYSIS 65
5.10.1 INDICATIVE SELLING PRICE OF DRYERS, BY PRODUCT 66
5.10.2 INDICATIVE SELLING PRICE OF DRYERS, BY REGION 66
5.11 KEY CONFERENCES AND EVENTS, 2024–2025 68
5.12 UNMET NEEDS 69
5.13 END-USER EXPECTATIONS 70
5.14 IMPACT OF AI/GENERATIVE AI ON PHARMACEUTICAL DRYING EQUIPMENT MARKET 71
5.14.1 KEY USE CASES 72
5.15 ECOSYSTEM ANALYSIS 72
5.16 CASE STUDY ANALYSIS 73
5.16.1 CASE STUDY 1: IMPROVED VACUUM PRESSURE TO REDUCE DRYING TIME, INCREASE QUALITY, AND SAVE PRODUCTION COSTS 73
5.16.2 CASE STUDY 2: OPTIMIZED PARTICLE SIZE DISTRIBUTION FOR HIGH-POTENCY API PRODUCTION 74
5.16.3 CASE STUDY 3: INNOVATIVE CONTAINMENT SOLUTIONS FOR HIGH-POTENCY APIS TO ENHANCE NUTSCHE FILTER DRYER PERFORMANCE 74
5.17 SUPPLY CHAIN ANALYSIS 75
5.18 ADJACENT MARKET ANALYSIS 76
5.18.1 SPRAY DRYING EQUIPMENT MARKET 76
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 77
5.20 INVESTMENT AND FUNDING SCENARIO 77
6 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE 79
6.1 INTRODUCTION 80
6.2 SPRAY DRYERS 80
6.2.1 ABILITY TO MAINTAIN STABILITY OF THERMALLY SENSITIVE COMPOUNDS THROUGH RAPID DRYING TO PRESERVE DRUG EFFICACY 80
6.3 FREEZE DRYERS 82
6.3.1 RISING DEMAND FOR LYOPHILIZED PRODUCTS TO DRIVE MARKET 82
6.4 FLUIDIZED BED DRYERS 84
6.4.1 COST-EFFECTIVENESS AND UNIFORM DRYING TO SPUR DEMAND IN PHARMACEUTICAL MANUFACTURING FACILITIES 84
6.5 VACUUM DRYERS 86
6.5.1 VACUUM DRYERS TO MINIMIZE THERMAL DEGRADATION AND PROVIDE STABILITY TO HEAT-SENSITIVE MATERIALS 86
6.6 OTHER DRYERS 87
7 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION 90
7.1 INTRODUCTION 91
7.2 INDUSTRIAL-SCALE EQUIPMENT 91
7.2.1 RISING INVESTMENTS IN HIGH-QUALITY MANUFACTURING TO AUGMENT MARKET GROWTH 91
7.3 PILOT-SCALE EQUIPMENT 92
7.3.1 INCREASED PHARMACEUTICAL R&D INVESTMENTS AND FOCUS ON EFFECTIVE QUALITY CONTROL IN LARGER OPERATIONS TO DRIVE MARKET 92
7.4 LABORATORY-SCALE EQUIPMENT 94
7.4.1 COST-EFFECTIVENESS, EASY OPERATION, AND LOW MAINTENANCE NEEDS TO FUEL MARKET GROWTH 94
8 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER 95
8.1 INTRODUCTION 96
8.2 PHARMACEUTICAL AND BIOTECH COMPANIES 96
8.2.1 INCREASED INVESTMENTS FOR BETTER PRODUCTION EFFICIENCY IN PHARMACEUTICAL INDUSTRY TO DRIVE MARKET 96
8.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS 97
8.3.1 INCREASED OUTSOURCING OF RESEARCH AND MANUFACTURING PROCESSES BY PHARMA COMPANIES TO PROPEL MARKET GROWTH 97
8.4 RESEARCH ACADEMIES AND UNIVERSITIES 98
8.4.1 RISING DEMAND FOR ADVANCED LABORATORY AND RESEARCH FACILITIES IN ACADEMIC SETTINGS TO DRIVE MARKET 98
9 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY REGION 100
9.1 INTRODUCTION 101
9.2 NORTH AMERICA 102
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 105
9.2.2 US 105
9.2.2.1 US to dominate North American pharmaceutical drying equipment market during forecast period 105
9.2.3 CANADA 107
9.2.3.1 Robust pharmaceutical sector and advancements in drug development to aid market growth 107
9.3 EUROPE 109
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 111
9.3.2 GERMANY 112
9.3.2.1 Increased R&D investments by key players and technological advancements to support market growth 112
9.3.3 FRANCE 114
9.3.3.1 Rising investments in bioproduction capacities to spur market growth 114
9.3.4 ITALY 116
9.3.4.1 Growing demand for biologics and biopharmaceuticals to boost market growth 116
9.3.5 UK 118
9.3.5.1 Increased government investments in pharmaceuticals and clinical trials to propel market growth 118
9.3.6 SPAIN 120
9.3.6.1 Increasing collaborations between drying equipment manufacturing companies to aid market growth 120
9.3.7 REST OF EUROPE 122
9.4 ASIA PACIFIC 124
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 127
9.4.2 CHINA 127
9.4.2.1 Technological advancements and strategic expansions by key international players to augment market growth 127
9.4.3 JAPAN 129
9.4.3.1 High investments in manufacturing capabilities and increased geriatric population to aid market growth 129
9.4.4 INDIA 132
9.4.4.1 Increasing investments in manufacturing facilities to propel market growth 132
9.4.5 AUSTRALIA 134
9.4.5.1 Rising demand for pharmaceuticals and increasing advancements in drug formulations to drive market 134
9.4.6 SOUTH KOREA 136
9.4.6.1 Increased popularity of CDMOs for pharmaceutical production to fuel market growth 136
9.4.7 REST OF ASIA PACIFIC 138
9.5 LATIN AMERICA 140
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 142
9.5.2 BRAZIL 142
9.5.2.1 Advanced biologics sector and increased demand for biosimilars to drive market 142
9.5.3 MEXICO 144
9.5.3.1 Burgeoning pharmaceutical industry and favorable trade agreements to propel market growth 144
9.5.4 REST OF LATIN AMERICA 146
9.6 MIDDLE EAST & AFRICA 148
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 150
9.6.2 GCC COUNTRIES 150
9.6.2.1 Expansion of pharmaceutical manufacturing companies to drive market 150
9.6.3 REST OF MIDDLE EAST & AFRICA 152
10 COMPETITIVE LANDSCAPE 156
10.1 INTRODUCTION 156
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 156
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET 156
10.3 REVENUE ANALYSIS, 2021–2023 157
10.4 MARKET SHARE ANALYSIS, 2023 158
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 160
10.5.1 STARS 160
10.5.2 EMERGING LEADERS 160
10.5.3 PERVASIVE PLAYERS 160
10.5.4 PARTICIPANTS 161
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 162
10.5.5.1 Company footprint 162
10.5.5.2 Type footprint 163
10.5.5.3 Scale of operation footprint 163
10.5.5.4 End-user footprint 164
10.5.5.5 Region footprint 165
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 166
10.6.1 PROGRESSIVE COMPANIES 166
10.6.2 RESPONSIVE COMPANIES 166
10.6.3 DYNAMIC COMPANIES 166
10.6.4 STARTING BLOCKS 166
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 168
10.7 COMPANY VALUATION AND FINANCIAL METRICS 170
10.7.1 FINANCIAL METRICS 170
10.7.2 COMPANY VALUATION 170
10.8 BRAND/PRODUCT COMPARISON 171
10.9 COMPETITIVE SCENARIO 171
10.9.1 PRODUCT LAUNCHES 172
10.9.2 DEALS 172
10.9.3 EXPANSIONS 173
11 COMPANY PROFILES 174
11.1 KEY PLAYERS 174
11.1.1 GEA GROUP AKTIENGESELLSCHAFT 174
11.1.1.1 Business overview 174
11.1.1.2 Products offered 175
11.1.1.3 Recent developments 177
11.1.1.3.1 Deals 177
11.1.1.4 MnM view 177
11.1.1.4.1 Right to win 177
11.1.1.4.2 Strategic choices 177
11.1.1.4.3 Weaknesses and competitive threats 178
11.1.2 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA 179
11.1.2.1 Business overview 179
11.1.2.2 Products offered 180
11.1.2.3 MnM view 181
11.1.2.3.1 Right to win 181
11.1.2.3.2 Strategic choices 181
11.1.2.3.3 Weaknesses and competitive threats 181
11.1.3 ATS CORPORATION 182
11.1.3.1 Business overview 182
11.1.3.2 Products offered 184
11.1.3.3 Recent developments 185
11.1.3.3.1 Product launches 185
11.1.3.3.2 Deals 185
11.1.3.3.3 Expansions 185
11.1.3.4 MnM view 186
11.1.3.4.1 Right to win 186
11.1.3.4.2 Strategic choices 186
11.1.3.4.3 Weaknesses and competitive threats 186
11.1.4 HOSOKAWA MICRON GROUP 187
11.1.4.1 Business overview 187
11.1.4.2 Products offered 188
11.1.4.3 MnM view 189
11.1.4.3.1 Right to win 189
11.1.4.3.2 Strategic choices 189
11.1.4.3.3 Weaknesses and competitive threats 189
11.1.5 FREUND CORP. 190
11.1.5.1 Business overview 190
11.1.5.2 Products offered 192
11.1.6 SYNTEGON TECHNOLOGY GMBH 193
11.1.6.1 Business overview 193
11.1.6.2 Products offered 193
11.1.6.3 Recent developments 194
11.1.6.3.1 Deals 194
11.1.7 BÜCHI LABORTECHNIK AG 195
11.1.7.1 Business overview 195
11.1.7.2 Products offered 195
11.1.7.3 Recent developments 196
11.1.7.3.1 Product launches 196
11.1.8 OPTIMA 197
11.1.8.1 Business overview 197
11.1.8.2 Products offered 197
11.1.9 MECHATECH SYSTEMS LTD. 199
11.1.9.1 Business overview 199
11.1.9.2 Products offered 200
11.1.10 BEW ENGINEERING 201
11.1.10.1 Business overview 201
11.1.10.2 Products offered 202
11.2 OTHER PLAYERS 203
11.2.1 ZIRBUS TECHNOLOGY GMBH 203
11.2.2 SPX FLOW, INC. 204
11.2.3 EUROPEAN SPRAYDRY TECHNOLOGIES 205
11.2.4 YAMATO SCIENTIFIC CO., LTD. 206
11.2.5 SAKA 207
11.2.6 ILSHIN BIOBASE 208
11.2.7 OKAWARA MFG. CO., LTD. 209
11.2.8 CHANGZHOU CHANGJIANG DRYING EQUIPMENT CO., LTD. 210
11.2.9 BACHILLER 211
11.2.10 MILLROCK TECHNOLOGY, INC. 212
11.2.11 MARTIN CHRIST GEFRIERTROCKNUNGSANLAGEN GMBH 213
11.2.12 LABCONCO 214
11.2.13 O’HARA TECHNOLOGIES 215
11.2.14 COOLVACUUM TECHNOLOGIES, SL 216
11.2.15 SHACHI ENGINEERING PVT. LTD. 217
12 APPENDIX 218
12.1 DISCUSSION GUIDE 218
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 223
12.3 CUSTOMIZATION OPTIONS 225
12.4 RELATED REPORTS 225
12.5 AUTHOR DETAILS 226
LIST OF TABLES
TABLE 1 PHARMACEUTICAL DRYING EQUIPMENT MARKET: INCLUSIONS & EXCLUSIONS 25
TABLE 2 CURRENCY CONVERSION RATES 26
TABLE 3 PHARMACEUTICAL DRYING EQUIPMENT MARKET: STUDY ASSUMPTIONS 39
TABLE 4 PHARMACEUTICAL DRYING EQUIPMENT MARKET: RISK ASSESSMENT 39
TABLE 5 PHARMACEUTICAL DRYING EQUIPMENT MARKET: PORTER’S FIVE FORCES 53
TABLE 6 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR PHARMACEUTICAL DRYING EQUIPMENT 55
TABLE 7 KEY BUYING CRITERIA FOR PHARMACEUTICAL DRYING EQUIPMENT 56
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 58
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 59
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 59
TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 60
TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT
AGENCIES, AND OTHER ORGANIZATIONS 60
TABLE 13 LIST OF PATENTS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET, 2014−2024 63
TABLE 14 IMPORT DATA FOR HS CODE 8419, BY COUNTRY, 2018–2023 (USD MILLION) 64
TABLE 15 EXPORT DATA FOR HS CODE 8419, BY COUNTRY, 2018–2023 (USD MILLION) 65
TABLE 16 INDICATIVE SELLING PRICING OF DRYERS, 2021–2023 66
TABLE 17 INDICATIVE SELLING PRICE OF DRYERS, BY REGION, 2022–2024 66
TABLE 18 PHARMACEUTICAL DRYING EQUIPMENT MARKET: KEY CONFERENCES AND EVENTS, JANUARY 2024–DECEMBER 2025 68
TABLE 19 PHARMACEUTICAL DRYING EQUIPMENT MARKET: UNMET NEEDS 69
TABLE 20 PHARMACEUTICAL DRYING EQUIPMENT MARKET: END-USER EXPECTATIONS 70
TABLE 21 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 80
TABLE 22 SPRAY DRYERS OFFERED BY KEY PLAYERS 81
TABLE 23 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR SPRAY DRYERS,
BY COUNTRY, 2022–2029 (USD MILLION) 82
TABLE 24 FREEZE DRYERS OFFERED BY KEY PLAYERS 83
TABLE 25 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR FREEZE DRYERS,
BY COUNTRY, 2022–2029 (USD MILLION) 84
TABLE 26 FLUIDIZED BED DRYERS OFFERED BY KEY PLAYERS 85
TABLE 27 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR FLUIDIZED BED DRYERS,
BY COUNTRY, 2022–2029 (USD MILLION) 85
TABLE 28 VACUUM DRYERS OFFERED BY KEY PLAYERS 86
TABLE 29 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR VACUUM DRYERS,
BY COUNTRY, 2022–2029 (USD MILLION) 87
TABLE 30 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR OTHER DRYERS,
BY COUNTRY, 2022–2029 (USD MILLION) 88
TABLE 31 OTHER DRYERS OFFERED BY KEY PLAYERS 89
TABLE 32 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 91
TABLE 33 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR INDUSTRIAL-SCALE EQUIPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 92
TABLE 34 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR PILOT-SCALE EQUIPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 93
TABLE 35 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR LABORATORY-SCALE EQUIPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 94
TABLE 36 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 96
TABLE 37 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 97
TABLE 38 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 98
TABLE 39 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR RESEARCH ACADEMIES AND UNIVERSITIES, BY COUNTRY, 2022–2029 (USD MILLION) 99
TABLE 40 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY REGION,
2022–2029 (USD MILLION) 102
TABLE 41 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 103
TABLE 42 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 104
TABLE 43 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 104
TABLE 44 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 105
TABLE 45 US: KEY MACROINDICATORS 106
TABLE 46 US: PHARMACEUTICAL INDUSTRY LANDSCAPE 106
TABLE 47 US: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 106
TABLE 48 US: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE
OF OPERATION, 2022–2029 (USD MILLION) 107
TABLE 49 US: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 107
TABLE 50 CANADA: KEY MACROINDICATORS 108
TABLE 51 CANADA: PHARMACEUTICAL INDUSTRY LANDSCAPE 108
TABLE 52 TOP FIVE EXPORTERS OF PHARMACEUTICAL PRODUCTS TO CANADA 108
TABLE 53 CANADA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 108
TABLE 54 CANADA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 109
TABLE 55 CANADA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 109
TABLE 56 EUROPE: PHARMACEUTICAL INDUSTRY LANDSCAPE 110
TABLE 57 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 110
TABLE 58 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 110
TABLE 59 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 111
TABLE 60 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 111
TABLE 61 GERMANY: KEY MACROINDICATORS 112
TABLE 62 GERMANY: PHARMACEUTICAL INDUSTRY LANDSCAPE 112
TABLE 63 GERMANY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 113
TABLE 64 GERMANY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 113
TABLE 65 GERMANY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 113
TABLE 66 FRANCE: KEY MACROINDICATORS 114
TABLE 67 FRANCE: PHARMACEUTICAL INDUSTRY LANDSCAPE 114
TABLE 68 FRANCE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 115
TABLE 69 FRANCE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 115
TABLE 70 FRANCE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 116
TABLE 71 ITALY: KEY MACROINDICATORS 117
TABLE 72 ITALY: PHARMACEUTICAL INDUSTRY LANDSCAPE 117
TABLE 73 ITALY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 117
TABLE 74 ITALY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 118
TABLE 75 ITALY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 118
TABLE 76 UK: KEY MACROINDICATORS 119
TABLE 77 UK: PHARMACEUTICAL INDUSTRY LANDSCAPE 119
TABLE 78 UK: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 119
TABLE 79 UK: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 120
TABLE 80 UK: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 120
TABLE 81 SPAIN: KEY MACROINDICATORS 121
TABLE 82 SPAIN: PHARMACEUTICAL INDUSTRY LANDSCAPE 121
TABLE 83 SPAIN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 121
TABLE 84 SPAIN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 121
TABLE 85 SPAIN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 122
TABLE 86 SWITZERLAND: PHARMACEUTICAL INDUSTRY LANDSCAPE 122
TABLE 87 POLAND: PHARMACEUTICAL INDUSTRY LANDSCAPE 122
TABLE 88 BELGIUM: PHARMACEUTICAL PRODUCTION VALUE (USD MILLION) 123
TABLE 89 AUSTRIA: PHARMACEUTICAL PRODUCTION VALUE (USD MILLION) 123
TABLE 90 IRELAND: PHARMACEUTICAL INDUSTRY LANDSCAPE 123
TABLE 91 REST OF EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 123
TABLE 92 REST OF EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 124
TABLE 93 REST OF EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION) 124
TABLE 94 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 95 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 126
TABLE 96 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 126
TABLE 97 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 127
TABLE 98 CHINA: KEY MACROINDICATORS 128
TABLE 99 CHINA: PHARMACEUTICAL INDUSTRY LANDSCAPE 128
TABLE 100 CHINA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 128
TABLE 101 CHINA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 129
TABLE 102 CHINA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 129
TABLE 103 JAPAN: KEY MACROINDICATORS 130
TABLE 104 JAPAN: PHARMACEUTICAL INDUSTRY LANDSCAPE 130
TABLE 105 JAPAN: PHARMACEUTICAL PRODUCTION, BY DOSAGE FORM 130
TABLE 106 JAPAN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 131
TABLE 107 JAPAN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 131
TABLE 108 JAPAN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 132
TABLE 109 INDIA: KEY MACROINDICATORS 132
TABLE 110 INDIA: PHARMACEUTICAL INDUSTRY LANDSCAPE 133
TABLE 111 INDIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 133
TABLE 112 INDIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 133
TABLE 113 INDIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 134
TABLE 114 AUSTRALIA: KEY MACROINDICATORS 134
TABLE 115 AUSTRALIA: PHARMACEUTICAL INDUSTRY LANDSCAPE 135
TABLE 116 AUSTRALIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 135
TABLE 117 AUSTRALIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 135
TABLE 118 AUSTRALIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 136
TABLE 119 SOUTH KOREA: KEY MACROINDICATORS 136
TABLE 120 SOUTH KOREA: PHARMACEUTICAL MANUFACTURERS SIZE 137
TABLE 121 SOUTH KOREA: PHARMACEUTICAL PRODUCTION VALUE (USD BILLION) 137
TABLE 122 SOUTH KOREA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 137
TABLE 123 SOUTH KOREA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 138
TABLE 124 SOUTH KOREA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION) 138
TABLE 125 SINGAPORE: PHARMACEUTICAL INDUSTRY LANDSCAPE 139
TABLE 126 SINGAPORE: PHARMACEUTICAL AND BIOLOGICAL PRODUCTION INDEX
(2019–2023) 139
TABLE 127 MALAYSIA: PHARMACEUTICAL INDUSTRY LANDSCAPE 139
TABLE 128 REST OF ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY TYPE, 2022–2029 (USD MILLION) 139
TABLE 129 REST OF ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 140
TABLE 130 REST OF ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION) 140
TABLE 131 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 132 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 141
TABLE 133 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 141
TABLE 134 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION) 142
TABLE 135 BRAZIL: KEY MACROINDICATORS 143
TABLE 136 BRAZIL: PHARMACEUTICAL INDUSTRY LANDSCAPE 143
TABLE 137 BRAZIL: IMPORT VALUE OF PHARMACEUTICAL PRODUCTS (2020–2023) 143
TABLE 138 BRAZIL: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 143
TABLE 139 BRAZIL: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 144
TABLE 140 BRAZIL: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 144
TABLE 141 MEXICO: KEY MACROINDICATORS 145
TABLE 142 MEXICO: PHARMACEUTICAL INDUSTRY LANDSCAPE 145
TABLE 143 MEXICO: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE (2020–2023) 145
TABLE 144 MEXICO: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 145
TABLE 145 MEXICO: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 146
TABLE 146 MEXICO: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 146
TABLE 147 ARGENTINA: PHARMACEUTICAL INDUSTRY LANDSCAPE 147
TABLE 148 ARGENTINA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE 147
TABLE 149 REST OF LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY TYPE, 2022–2029 (USD MILLION) 147
TABLE 150 REST OF LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 147
TABLE 151 REST OF LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION) 148
TABLE 152 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY REGION, 2022–2029 (USD MILLION) 148
TABLE 153 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY TYPE, 2022–2029 (USD MILLION) 149
TABLE 154 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 149
TABLE 155 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION) 149
TABLE 156 UAE: GROWTH RATE OF PHARMACEUTICAL MANUFACTURING PLANT,
2010 VS. 2021 150
TABLE 157 SAUDI ARABIA: PHARMACEUTICAL INDUSTRY LANDSCAPE 150
TABLE 158 GCC COUNTRIES: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY TYPE, 2022–2029 (USD MILLION) 151
TABLE 159 GCC COUNTRIES: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 151
TABLE 160 GCC COUNTRIES: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION) 151
TABLE 161 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INDUSTRY LANDSCAPE 152
TABLE 162 SOUTH AFRICA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE 152
TABLE 163 EGYPT: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE 153
TABLE 164 GHANA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE 153
TABLE 165 KENYA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE 153
TABLE 166 ETHIOPIA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE 153
TABLE 167 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 154
TABLE 168 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 154
TABLE 169 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 155
TABLE 170 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET 156
TABLE 171 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DEGREE OF COMPETITION 159
TABLE 172 PHARMACEUTICAL DRYING EQUIPMENT MARKET: TYPE FOOTPRINT 163
TABLE 173 PHARMACEUTICAL DRYING EQUIPMENT MARKET:
SCALE OF OPERATION FOOTPRINT 163
TABLE 174 PHARMACEUTICAL DRYING EQUIPMENT MARKET: END-USER FOOTPRINT 164
TABLE 175 PHARMACEUTICAL DRYING EQUIPMENT MARKET: REGION FOOTPRINT 165
TABLE 176 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYER 168
TABLE 177 PHARMACEUTICAL DRYING EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 169
TABLE 178 PHARMACEUTICAL DRYING EQUIPMENT MARKET: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024 172
TABLE 179 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DEALS,
JANUARY 2021–AUGUST 2024 172
TABLE 180 PHARMACEUTICAL DRYING EQUIPMENT MARKET: EXPANSIONS,
JANUARY 2021–AUGUST 2024 173
TABLE 181 GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW 174
TABLE 182 GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS OFFERED 175
TABLE 183 GEA GROUP AKTIENGESELLSCHAFT: DEALS, JANUARY 2021–AUGUST 2024 177
TABLE 184 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: COMPANY OVERVIEW 179
TABLE 185 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: PRODUCTS OFFERED 180
TABLE 186 ATS CORPORATION: COMPANY OVERVIEW 182
TABLE 187 ATS CORPORATION: PRODUCTS OFFERED 184
TABLE 188 ATS CORPORATION PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024 185
TABLE 189 ATS CORPORATION: DEALS, JANUARY 2021–AUGUST 2024 185
TABLE 190 ATS CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2024 185
TABLE 191 HOSOKAWA MICRON GROUP: COMPANY OVERVIEW 187
TABLE 192 HOSOKAWA MICRON GROUP: PRODUCTS OFFERED 188
TABLE 193 FREUND CORP.: COMPANY OVERVIEW 190
TABLE 194 FREUND CORP.: PRODUCTS OFFERED 192
TABLE 195 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW 193
TABLE 196 SYNTEGON TECHNOLOGY GMBH: PRODUCTS OFFERED 193
TABLE 197 SYNTEGON TECHNOLOGY GMBH: DEALS, JANUARY 2021–AUGUST 2024 194
TABLE 198 BÜCHI LABORTECHNIK AG.: COMPANY OVERVIEW 195
TABLE 199 BÜCHI LABORTECHNIK AG: PRODUCTS OFFERED 195
TABLE 200 BÜCHI LABORTECHNIK AG: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024 196
TABLE 201 OPTIMA: COMPANY OVERVIEW 197
TABLE 202 OPTIMA: PRODUCTS OFFERED 197
TABLE 203 MECHATECH SYSTEMS LTD.: COMPANY OVERVIEW 199
TABLE 204 MECHATECH SYSTEMS LTD.: PRODUCTS OFFERED 200
TABLE 205 BEW ENGINEERING: COMPANY OVERVIEW 201
TABLE 206 BEW ENGINEERING: PRODUCTS OFFERED 202
TABLE 207 ZIRBUS TECHNOLOGY GMBH: COMPANY OVERVIEW 203
TABLE 208 SPX FLOW, INC.: COMPANY OVERVIEW 204
TABLE 209 EUROPEAN SPRAYDRY TECHNOLOGIES: COMPANY OVERVIEW 205
TABLE 210 YAMATO SCIENTIFIC CO., LTD.: COMPANY OVERVIEW 206
TABLE 211 SAKA: COMPANY OVERVIEW 207
TABLE 212 ILSHIN BIOBASE: COMPANY OVERVIEW 208
TABLE 213 OKAWARA MFG. CO., LTD.: COMPANY OVERVIEW 209
TABLE 214 CHANGZHOU CHANGJIANG DRYING EQUIPMENT CO., LTD.: COMPANY OVERVIEW 210
TABLE 215 BACHILLER: COMPANY OVERVIEW 211
TABLE 216 MILLROCK TECHNOLOGY, INC.: COMPANY OVERVIEW 212
TABLE 217 MARTIN CHRIST GEFRIERTROCKNUNGSANLAGEN GMBH: COMPANY OVERVIEW 213
TABLE 218 LABCONCO: COMPANY OVERVIEW 214
TABLE 219 O’HARA TECHNOLOGIES: COMPANY OVERVIEW 215
TABLE 220 COOLVACUUM TECHNOLOGIES, SL: COMPANY OVERVIEW 216
TABLE 221 SHACHI ENGINEERING PVT. LTD.: COMPANY OVERVIEW 217
LIST OF FIGURES
FIGURE 1 PHARMACEUTICAL DRYING EQUIPMENT MARKET: SEGMENTS
AND REGIONS COVERED 24
FIGURE 2 PHARMACEUTICAL DRYING EQUIPMENT MARKET: YEARS CONSIDERED 25
FIGURE 3 PHARMACEUTICAL DRYING EQUIPMENT MARKET: RESEARCH DESIGN 28
FIGURE 4 PHARMACEUTICAL DRYING EQUIPMENT MARKET: KEY DATA FROM
SECONDARY SOURCES 30
FIGURE 5 PHARMACEUTICAL DRYING EQUIPMENT MARKET: PRIMARY SOURCES 31
FIGURE 6 PHARMACEUTICAL DRYING EQUIPMENT MARKET: KEY DATA FROM PRIMARIES 32
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 32
FIGURE 8 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 33
FIGURE 9 PHARMACEUTICAL DRYING EQUIPMENT MARKET: TOP-DOWN APPROACH 34
FIGURE 10 MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT 35
FIGURE 11 IMPACT OF CAGR ON DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES (2024–2029) 36
FIGURE 12 PHARMACEUTICAL DRYING EQUIPMENT MARKET: CAGR PROJECTIONS 36
FIGURE 13 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DATA TRIANGULATION 38
FIGURE 14 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2024 VS. 2029 (USD MILLION) 40
FIGURE 15 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION,
2024 VS. 2029 (USD MILLION) 41
FIGURE 16 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2024 VS. 2029 (USD MILLION) 41
FIGURE 17 PHARMACEUTICAL DRYING EQUIPMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 42
FIGURE 18 RISING INVESTMENT BY PHARMACEUTICAL FACILITIES TO DRIVE MARKET 43
FIGURE 19 PHARMACEUTICAL AND BIOTECH COMPANIES COMMANDED LARGEST MARKET SHARE IN 2023 44
FIGURE 20 INDIA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD 45
FIGURE 21 ASIA PACIFIC TO GROW AT HIGHEST GROWTH RATE FROM 2024 TO 2029 46
FIGURE 22 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATE
DURING FORECAST PERIOD 46
FIGURE 23 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47
FIGURE 24 PHARMACEUTICAL DRYING EQUIPMENT MARKET:
PORTER’S FIVE FORCES ANALYSIS 53
FIGURE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR PHARMACEUTICAL DRYING EQUIPMENT 55
FIGURE 26 KEY BUYING CRITERIA FOR PHARMACEUTICAL DRYING EQUIPMENT 56
FIGURE 27 NUMBER OF PATENTS PUBLISHED (JANUARY 2014–AUGUST 2024) 61
FIGURE 28 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR PHARMACEUTICAL DRYING EQUIPMENT PATENTS (JANUARY 2014−AUGUST 2024) 62
FIGURE 29 TOP APPLICANT COUNTRIES/REGIONS FOR PHARMACEUTICAL DRYING EQUIPMENT (JANUARY 2014−JULY 2024) 63
FIGURE 30 AVERAGE SELLING PRICE OF SINGLE-LIMB BREATHING CIRCUITS (2024) 67
FIGURE 31 MARKET POTENTIAL OF AI TO ENHANCE EFFICACY AND PRODUCT QUALITY 71
FIGURE 32 PHARMACEUTICAL DRYING EQUIPMENT MARKET: ECOSYSTEM ANALYSIS 73
FIGURE 33 PHARMACEUTICAL DRYING EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS 75
FIGURE 34 SPRAY DRYING EQUIPMENT: MARKET OVERVIEW 76
FIGURE 35 PHARMACEUTICAL DRYING EQUIPMENT MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 77
FIGURE 36 PHARMACEUTICAL DRYING EQUIPMENT MARKET: INVESTMENT AND FUNDING SCENARIO (2020–2023) 77
FIGURE 37 PHARMACEUTICAL DRYING EQUIPMENT MARKET: GEOGRAPHIC SNAPSHOT 101
FIGURE 38 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET SNAPSHOT 103
FIGURE 39 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET SNAPSHOT 125
FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS (2021–2023) 158
FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023) 159
FIGURE 42 PHARMACEUTICAL DRYING EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 161
FIGURE 43 PHARMACEUTICAL DRYING EQUIPMENT MARKET: COMPANY FOOTPRINT 162
FIGURE 44 PHARMACEUTICAL DRYING EQUIPMENT MARKET:
COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 167
FIGURE 45 EV/EBITDA OF KEY VENDORS 170
FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 170
FIGURE 47 PHARMACEUTICAL DRYING EQUIPMENT MARKET:
BRAND/PRODUCT COMPARATIVE ANALYSIS 171
FIGURE 48 GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT 175
FIGURE 49 ATS CORPORATION: COMPANY SNAPSHOT 183
FIGURE 50 HOSOKAWA MICRON GROUP: COMPANY SNAPSHOT 188
FIGURE 51 FREUND CORP.: COMPANY SNAPSHOT 191
FIGURE 52 BEW ENGINEERING: COMPANY SNAPSHOT 201
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11